PGNewsroom

Blog Post
Link to Article

Introducing PGmaxTM Tests

Published on

An exciting new name for some old favorites. 

Blog Post
Link to Article

Introducing Patient Prompt Pay Discount

Published on

In an effort to make genetic testing more accessible, we’re now offering a Patient Prompt Pay (self-pay) discount of 10% if payment is received in full when we receive the test requisition form (TRF).

Press Release
Link to Article

PreventionGenetics Receives FDA Approval for its Companion Diagnostic Genetic Test as a Class II Medical Device 

Published on

PreventionGenetics, a subsidiary of Exact Sciences Corp., announced today that it was recently granted marketing authorization for the POMC/PCSK1/LEPR companion diagnostic (CDx) genetic test as a Class II device by the Center for Devices and Radiological Health (CDRH), a division of the Food and Drug Administration (FDA). Developed in collaboration with Rhythm Pharmaceuticals, Inc., the test is the first FDA-authorized Class II molecular companion diagnostic device.

Blog Post
Link to Article

New PGnome Sequencing Backbone Available

Published on

We recently released an option for our pre-defined panels to be run on a PGnome® (genome) sequencing backbone. But you may be wondering … what’s a backbone?

Blog Post
Link to Article

Genetic Testing for Kidney Disorders

Published on

Inherited kidney diseases have an overall prevalence of ~6-8 in 10,000 births in the United States and Europe, and accounts for up to 37% of adults with renal diseases (Cocchi et al. 2020. PubMed ID: 32646915; Connaughton et al. 2019. PubMed ID: 30773290; Lata et al. 2018. PubMed ID: 29204651). Obtaining an early diagnosis for kidney disease is important for establishing optimal maintenance and treatment plans for patients and their families, which is why genetic testing has been increasingly integrated into clinical practice.